Balasa Dinverno & Foltz’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.73M | Buy |
3,402
+246
| +8% | +$138K | 0.11% | 76 |
|
|
2022
Q2 | $1.72M | Buy |
3,156
+269
| +9% | +$148K | 0.11% | 77 |
|
|
2022
Q1 | $1.71M | Sell |
2,887
-252
| -8% | -$145K | 0.12% | 82 |
|
|
2021
Q4 | $2.09M | Buy |
3,139
+210
| +7% | +$131K | 0.13% | 71 |
|
|
2021
Q3 | $1.67M | Buy |
2,929
+118
| +4% | +$64.8K | 0.12% | 87 |
|
|
2021
Q2 | $1.42M | Sell |
2,811
-254
| -8% | -$120K | 0.1% | 98 |
|
|
2021
Q1 | $1.4M | Buy |
3,065
+1
| +0% | +$477 | 0.11% | 90 |
|
|
2020
Q4 | $1.43M | Buy |
3,064
+971
| +46% | +$455K | 0.12% | 84 |
|
|
2020
Q3 | $924K | Sell |
2,093
-7
| -0.3% | -$2.89K | 0.09% | 99 |
|
|
2020
Q2 | $761K | Sell |
2,100
-55
| -3% | -$18.4K | 0.08% | 101 |
|
|
2020
Q1 | $611K | Sell |
2,155
-162
| -7% | -$51.1K | 0.08% | 119 |
|
|
2019
Q4 | $753K | Buy |
2,317
+18
| +0.8% | +$5.46K | 0.08% | 117 |
|
|
2019
Q3 | $670K | Buy |
2,299
+32
| +1% | +$9.16K | 0.08% | 122 |
|
|
2019
Q2 | $666K | Buy |
2,267
+23
| +1% | +$6.33K | 0.08% | 117 |
|
|
2019
Q1 | $614K | Buy |
2,244
+6
| +0.3% | +$1.49K | 0.07% | 114 |
|
|
2018
Q4 | $501K | Buy |
2,238
+46
| +2% | +$10.8K | 0.06% | 126 |
|
|
2018
Q3 | $535K | Buy |
2,192
+31
| +1% | +$7.13K | 0.06% | 132 |
|
|
2018
Q2 | $448K | Buy |
2,161
+22
| +1% | +$4.67K | 0.06% | 136 |
|
|
2018
Q1 | $442K | Sell |
2,139
-102
| -5% | -$21.4K | 0.07% | 133 |
|
|
2017
Q4 | $426K | Sell |
2,241
-18
| -0.8% | -$3.45K | 0.06% | 132 |
|
|
2017
Q3 | $427K | Buy |
2,259
+132
| +6% | +$23.9K | 0.07% | 131 |
|
|
2017
Q2 | $371K | Sell |
2,127
-4
| -0.2% | -$672 | 0.06% | 144 |
|
|
2017
Q1 | $327K | Sell |
2,131
-15
| -0.7% | -$2.29K | 0.06% | 146 |
|
|
2016
Q4 | $303K | Sell |
2,146
-93
| -4% | -$13.7K | 0.05% | 143 |
|
|
2016
Q3 | $356K | Sell |
2,239
-90
| -4% | -$13.9K | 0.07% | 122 |
|
|
2016
Q2 | $344K | Buy |
2,329
+164
| +8% | +$24.2K | 0.06% | 124 |
|
|
2016
Q1 | $307K | Buy |
2,165
+84
| +4% | +$11.3K | 0.05% | 132 |
|
|
2015
Q4 | $295K | Buy |
2,081
+33
| +2% | +$4.4K | 0.05% | 156 |
|
|
2015
Q3 | $250K | Buy |
2,048
+72
| +4% | +$9.38K | 0.04% | 164 |
|
|
2015
Q2 | $256K | Sell |
1,976
-40
| -2% | -$5.21K | 0.04% | 165 |
|
|
2015
Q1 | $271K | Sell |
2,016
-128
| -6% | -$16.5K | 0.04% | 157 |
|
|
2014
Q4 | $269K | Sell |
2,144
-62
| -3% | -$7.54K | 0.04% | 156 |
|
|
2014
Q3 | $268K | Buy |
2,206
+96
| +5% | +$11.7K | 0.04% | 142 |
|
|
2014
Q2 | $249K | Buy |
2,110
+356
| +20% | +$41.9K | 0.03% | 153 |
|
|
2014
Q1 | $211K | Buy |
+1,754
| New | +$209K | 0.03% | 159 |
|
Other funds holding TMO
Balasa Dinverno & Foltz's TMO Position: Q3 2022 in Review
Balasa Dinverno & Foltz increased its Thermo Fisher Scientific (TMO) stake by 7.8% in Q3 2022, buying an estimated $138K and bringing the position to 3,402 shares worth $1.73M. The position accounts for 0.11% of the portfolio, ranked #76.
Balasa Dinverno & Foltz first reported a position in TMO in Q1 2014 and has held it in 35 quarters since. The position peaked at $2.09M in Q4 2021. 2,266 funds tracked by Wall St. Rank hold TMO as of Q3 2022.
- Balasa Dinverno & Foltz held 3,402 shares of Thermo Fisher Scientific worth $1.73M as of Q3 2022.
- Balasa Dinverno & Foltz bought 246 Thermo Fisher Scientific shares in Q3 2022, an estimated $138K.
- Thermo Fisher Scientific made up 0.11% of Balasa Dinverno & Foltz's portfolio in Q3 2022, its #76 holding.
- Balasa Dinverno & Foltz first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 35 quarters since.
- Balasa Dinverno & Foltz's Thermo Fisher Scientific position peaked at $2.09M in Q4 2021.
- 2,266 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.
Based on Balasa Dinverno & Foltz's 13F filing for Q3 2022, filed 25 Oct 2022.